Vimarsana
Biggest News Aggregation in the World

Page 5 - Trial Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Development Today - Breaking & Trending Today

CSPAN3 FDA Transparency - Panel 2 - Investors February 7, 2018 - Vimarsana News

CSPAN3 FDA Transparency - Panel 2 - Investors February 7, 2018

Thank you so much for coming. Thank you. I forgot to turn my mike on. Jonathan is a partner with deerfield management and chairman of the deerfield institute. He joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior to joining deerfield for more than 16 years, jonathan was with Warburg Pincus where he led investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions related to health care and medical innovation and served on the executive committee of the board of the national Ventu...

CSPAN Discussion Focuses On The Future Of North Korea May 30, 2017 - Vimarsana News

CSPAN Discussion Focuses On The Future Of North Korea May 30, 2017

Thanks very much for coming to this event for a discussion of north korea boom or bust. Dropout, we have a 30 rate for attendance. I think today we had a 30 increase in attendance. I think that is a true to our speakers and the issue at hand, which is one of the top Security Issues facing not just the United States, but the world. Of a dialoguepart where we seek to address and shed light on the issues that come up. The dialogue is a gathering of defense ministers around the region and in other countries. There is one asian defense minister who will not be there. That is the north korean. I tri...

CSPAN Discussion Focuses On The Future Of North Korea May 31, 2017 - Vimarsana News

CSPAN Discussion Focuses On The Future Of North Korea May 31, 2017

Winning the presidency and the 20 17th elections in south korea the 20 17th elections in south korea. Thanks very much for coming to this event for a discussion of north korea. You will notice that clever play words. Normally we have a 30 chance drop a great for those who signal attendance. I think today we had a 30 increase in attendance. I think that is a true to our speakers and the issue at hand, which is one of the top Security Issues facing not just the United States, but the world. This event is part of a dialogue series where we seek to address and shed light on the issues that come up...

CSPAN3 Medical Cures And Innovation November 6, 2014 - Vimarsana News

CSPAN3 Medical Cures And Innovation November 6, 2014

One of the things to note on the impact, too, is we are finding that athletes are now failing the impact test on purpose so that their baseline is now lower to start out with. So that if in fact the concussion occurs, they dont have to get back to what truly is their normal baseline. But one that has been fabricated because of choices theyve made during the testtaking. So this is about changing the nature of this injury as well. And really getting people to care about their brains so that they dont make choices like that. And in this case, you mean, that that enables them to get back out on th...

CSPAN3 Medical Cures And Innovation November 6, 2014 - Vimarsana News

CSPAN3 Medical Cures And Innovation November 6, 2014

Good afternoon and welcome. Im councilman joe pitts. Welcome to the 16th Congressional District of pennsylvania. For your information, this meeting will be streamed live. Cspan is here. So you might want to keep that in mind. But id like to welcome everyone here, especially our distinguished panelists. And i have a short introductory comment to set the stage. Through the 21st century initiative, congress is taking a comprehensive look at the full arc of accelerating cures. From the discovery of clues and basic science, to streamlining the drug and Device Development process, to unleashing the ...